Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease
โ Scribed by W. Marz; H. Seydewitz; B. Winkelmann; M. Chen; M. Nauck; I. Witt
- Book ID
- 118557663
- Publisher
- The Lancet
- Year
- 1995
- Tongue
- English
- Weight
- 334 KB
- Volume
- 345
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The aim of our study was to determine the prevalence of the factor V mutation (position 1691 G->A) in patients with angiographically diagnosed coronary artery disease and myocardial infarction and, as a control, in blood donors. This mutation has already been proved to be the main genetic risk facto
To determine the prevalence of activated protein C resistance and the factor V Leiden mutation (position 1691, arginine 506 to glutamine substitution) in children with thrombosis, plasma samples from children with thrombosis were tested for activated protein C resistance. DNA was analyzed for the fa